Navigation Links
Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer

Interim Analysis of Phase 2 Clinical Data Published at the American Society of Clinical Oncology 43rd Annual Meeting

CHICAGO, June 04, 2007 /PRNewswire-FirstCall/ -- Pharmion Corporation today released interim findings from its Phase II, multi-center clinical study of Amrubicin, the company's third-generation synthetic anthracycline currently in development for the treatment of small cell lung cancer. These findings indicate favorable interim results in terms of response rate and safety when comparing Amrubicin to the current treatment standard, topotecan, in second-line treatment of platinum-sensitive small-cell lung cancer patients with extensive disease (ED-SCLC). The early results of this study were published online on the ASCO website during the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Ill. (June 1- 5, 2007).

"Oncologists have very limited treatment options available for patients with extensive-disease small cell lung cancer, and regrettably, patients with this disease still have an exceptionally poor prognosis," said Andrew R. Allen, chief medical officer of Pharmion. "We are encouraged by these initial results which suggest Amrubicin's potential to improve the treatment landscape for small cell lung cancer."

The trial compares Amrubicin and topotecan in patients with ED-SCLC that initially responded to first-line platinum-based therapy but recurred or progressed at least 90 days after completion of first-line treatment. Study participants are randomized 2:1 to receive either Amrubicin (40 mg/m2 via 5- min.infusion daily x 3 days) or topotecan (1.5 mg/m2 via 30-min. infusion daily x 5 days), both starting on Day 1 of a 21-day cycle.

Response data from 24 evaluable patients have been analyzed, 15 treated with Amrubicin and nine with topotecan. Of the 15 Amrubicin patients, 40 percent showed an objective tumor response, including two complete r
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
2. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
3. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
4. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
5. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
6. Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
7. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
8. CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP
9. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
10. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
11. New Poll Shows Men, Women Incorrectly Blame Symptoms of Low Testosterone on Normal Aging
Post Your Comments:
(Date:7/7/2015)... VALLEY, Pa. , July 7, 2015  Air Products ... of its medical oxygen supply systems—including high efficiency systems that ... 52 nd ASHE Annual Conference and Technical Exhibition in ... ASHE attendees are invited to stop by Air ... reduce their oxygen usage by as much as 30 percent, ...
(Date:7/7/2015)... Noting the need to step up federal ... by the rapidly consolidating pharmacy benefit manager (PBM) industry, ... Ohio Governor John Kasich ... to help pull back the curtain on PBM drug ... Governor Kasich for bringing badly-needed reform to secretive and ...
(Date:7/7/2015)... 7, 2015   Decision Resources Group ... dialysis patient management in the U.S. versus the ... U.S. and EU5 nephrologists from approximately 1,870 dialysis ... the most commonly used renal medications in dialysis ... considerably between the two regions.      Other ...
Breaking Medicine Technology:Air Products Highlights Reliability and Efficiency of Its Medical Oxygen Supply Systems at ASHE Conference and Exhibition 2National LTC Pharmacy Leader Praises Kasich Effort to Bring Transparency to PBM Drug Pricing 2National LTC Pharmacy Leader Praises Kasich Effort to Bring Transparency to PBM Drug Pricing 3Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 2Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 3
... China , April 29 /PRNewswire-Asia-FirstCall/ -- China Pharma,Holdings, Inc. (NYSE ... pharmaceuticals company in China , today announced,that it has retained CCG ... , , ... to working with CCG to establish more effective and,transparent communications channels with ...
... , April 29 Royal Philips Electronics ( ... provider of integration solutions in healthcare, to deploy the Orion Health Rhapsody® ... , , ... , , ...
Cached Medicine Technology:China Pharma Holdings, Inc. Retains CCG Investor Relations 2China Pharma Holdings, Inc. Retains CCG Investor Relations 3China Pharma Holdings, Inc. Retains CCG Investor Relations 4China Pharma Holdings, Inc. Retains CCG Investor Relations 5Philips and Orion Health Partner to Deliver on Enterprise Interoperability 2Philips and Orion Health Partner to Deliver on Enterprise Interoperability 3Philips and Orion Health Partner to Deliver on Enterprise Interoperability 4
(Date:7/7/2015)... Norfolk, NE (PRWEB) , ... July 07, 2015 ... ... imaging center for MRI services, is debuting their brand new website. The website’s ... MRI technology and a wider selection of patient tools, including requesting appointments online. ...
(Date:7/7/2015)... MA (PRWEB) , ... July 07, 2015 , ... The ... AIDS Action Committee of Massachusetts , and the Multicultural AIDS Coalition ... and other men who have sex with men (MSM) and transgender women, the ...
(Date:7/7/2015)... ... ... Law Group is pleased to announce the relocation of the firm's headquarters to 225 ... a state of the art building, located with easy access to New York City's ... "We are pleased to service our clients from such a premier location and we ...
(Date:7/7/2015)... Somerset, N.J. (PRWEB) , ... ... ... (NYSE: CTLT), the leading global provider of advanced delivery technologies and development ... has signed an exclusive licensing agreement with Excelimmune, Inc. to access its ...
(Date:7/7/2015)... R.I. (PRWEB) , ... July 07, 2015 , ... Summer ... the proper precautions, however, so Amica Insurance is sharing some safety tips. , Jean ... sports and gardening: , Leisure activities/sports, , Start slowly. Going ...
Breaking Medicine News(10 mins):Health News:Northeast Nebraska Imaging Launches New Patient Friendly Website 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 3Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2Health News:Amica Insurance Has 7 Summer Safety Tips 2
... TeamStaff, Inc.,(Nasdaq: TSTF ), a national provider of ... sold its Nursing Innovations,Per Diem business unit located in ... transaction is all cash and a sale of,substantially all ... on January 31, 2008. Other terms of the transaction ...
... CAMBRIDGE, England, January 30 The next generation ... of IT and different,expectations regarding healthcare than their ... by Cambridge, UK-based Wireless Healthcare,will increase the take ... being used by the elderly., In the ...
... national poll of medical,oncologists and hematologists, 91 percent ... 12-week period following the implementation,of the new CMS ... by US Oncology and conducted by KJT Group, ... survey of,community-based oncologists included closed and open-ended questions ...
... Hamilton, ON. January 30, 2007 Aggression, testosterone and ... but the support of a good female can, according ... unusual African species of fish. , The study, published ... highlights the complex relationship between social status, reproductive physiology ...
... Study found loss of consciousness increased chances of trauma ... -- Researchers report that soldiers who have suffered concussions ... experience post-traumatic stress disorder and other physical health problems. ... and/or health problems among those who had concussions versus ...
... AMCS ),a leader in radiology and medical image and information ... at the UBS Global Healthcare Services Conference in New,York., ... -- Tuesday, February 12, 2008 ... a.m. (Eastern Time), ...
Cached Medicine News:Health News:TeamStaff Sells Per Diem Business Unit 2Health News:TeamStaff Sells Per Diem Business Unit 3Health News:Increase in IT Skills Amongst the Elderly Will Boost Telecare Market 2Health News:91 Percent of Oncologists Polled Report Adverse Patient Events as Result of CMS National Coverage Decision on ESAs 2Health News:91 Percent of Oncologists Polled Report Adverse Patient Events as Result of CMS National Coverage Decision on ESAs 3Health News:91 Percent of Oncologists Polled Report Adverse Patient Events as Result of CMS National Coverage Decision on ESAs 4Health News:91 Percent of Oncologists Polled Report Adverse Patient Events as Result of CMS National Coverage Decision on ESAs 5Health News:91 Percent of Oncologists Polled Report Adverse Patient Events as Result of CMS National Coverage Decision on ESAs 6Health News:Females decide whether ambitious males float or flounder 2Health News:Concussion Raises PTSD Risk for Iraq Vets 2Health News:Concussion Raises PTSD Risk for Iraq Vets 3Health News:AMICAS to Present at UBS Global Healthcare Services Conference 2
Platelet agitator....
Reciprocating shaker specifically for platelet bags....
... produced by the adrenal cortex, the corpus ... with other steroids, progesterone is synthesized from ... [1,2]. Progesterone produced by the adrenal cortex ... other steroidogenic pathways, with only a small ...
... only physiologic hormone which significantly lowers blood ... of stimuli, including glucose and amino acids, ... circulation [1,2]. Although 50% of the insulin ... remainder enters the general circulation and is ...
Medicine Products: